Terms: = Pancreatic cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
258 results:
1. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via stat3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract] [Full Text] [Related]
2. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
3. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract] [Full Text] [Related]
4. A bibliometric and visual analysis of cancer-associated fibroblasts.
Yuan WC; Zhang JX; Chen HB; Yuan Y; Zhuang YP; Zhou HL; Li MH; Qiu WL; Zhou HG
Front Immunol; 2023; 14():1323115. PubMed ID: 38173726
[TBL] [Abstract] [Full Text] [Related]
5. cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and pancreatic cancer Initiation Via LAMA5/ITGA4 Axis.
Parte S; Kaur AB; Nimmakayala RK; Ogunleye AO; Chirravuri R; Vengoji R; Leon F; Nallasamy P; Rauth S; Alsafwani ZW; Lele S; Cox JL; Bhat I; Singh S; Batra SK; Ponnusamy MP
Gastroenterology; 2024 May; 166(5):842-858.e5. PubMed ID: 38154529
[TBL] [Abstract] [Full Text] [Related]
6. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Afaq F; Agarwal S; Bajpai P; Diffalha SA; Kim HG; Peter S; Khushman M; Chauhan SC; Mukherjee P; Varambally S; Manne U
Neoplasia; 2024 Jan; 47():100951. PubMed ID: 38039923
[TBL] [Abstract] [Full Text] [Related]
7. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
9. pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and stat3 interplay.
Vitali E; Valente G; Panzardi A; Laffi A; Zerbi A; Uccella S; Mazziotti G; Lania A
J Endocrinol Invest; 2024 May; 47(5):1101-1117. PubMed ID: 37882947
[TBL] [Abstract] [Full Text] [Related]
10. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
[TBL] [Abstract] [Full Text] [Related]
11. Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer.
Tang H; Kuang Y; Wu W; Peng B; Fu Q
Mol Med; 2023 Sep; 29(1):127. PubMed ID: 37710176
[TBL] [Abstract] [Full Text] [Related]
12. Polygonatum sibiricum Polysaccharide Inhibited Liver cancer in a Simulated Tumor Microenvironment by Eliminating TLR4/stat3 Pathway.
Xu Y; Guo Y; Lu C; Yu L; Fang C; Li C
Biol Pharm Bull; 2023; 46(9):1249-1259. PubMed ID: 37661404
[TBL] [Abstract] [Full Text] [Related]
13. Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma.
Khan IA; Singh N; Gunjan D; Gopi S; Dash NR; Gupta S; Saraya A
Immunogenetics; 2023 Oct; 75(5):433-443. PubMed ID: 37540314
[TBL] [Abstract] [Full Text] [Related]
14. [Apatinib Suppressed Macrophage-Mediated Malignant Behavior of Hepatocellular Carcinoma Cells via Modulation of VEGFR2/stat3/PD-L1 Signaling].
Yin T; Fu CB; Wu DD; Nie L; Chen H; Wang Y
Mol Biol (Mosk); 2023; 57(4):706-708. PubMed ID: 37528791
[TBL] [Abstract] [Full Text] [Related]
15. stat3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
16. Phloretin-induced stat3 inhibition suppresses pancreatic cancer growth and progression via enhancing Nrf2 activity.
Ruan Q; Wen C; Jin G; Yuan Z; Yang X; Wen Z; Huang G; Li G; Deng J; Bai Y
Phytomedicine; 2023 Sep; 118():154990. PubMed ID: 37494874
[TBL] [Abstract] [Full Text] [Related]
17. Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-stat3 axis.
Sarwar A; Zhu Z; Zhu M; Tang X; Su Q; Yang T; Tang W; Zhang Y
J Pharm Pharmacol; 2023 Oct; 75(10):1294-1309. PubMed ID: 37463100
[TBL] [Abstract] [Full Text] [Related]
18. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
[TBL] [Abstract] [Full Text] [Related]
19. m
Hu B; Gao J; Shi J; Wen P; Guo W; Zhang S
Mol Carcinog; 2023 Oct; 62(10):1599-1614. PubMed ID: 37449789
[TBL] [Abstract] [Full Text] [Related]
20. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
[TBL] [Abstract] [Full Text] [Related]
[Next]